Enzo Biochem, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 05/14/2025 | 5.18 M | $1.92 M | 0.00% | 9.90% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 2.08 M | $770.43 K | -12.05% | 3.98% |
| VANGUARD GROUP INC | 05/09/2025 | 1.86 M | $687.83 K | 0.00% | 3.55% |
| BLACKROCK, INC. | 05/02/2025 | 957.78 K | $354.38 K | -0.22% | 1.83% |
| MINK BROOK ASSET MANAGEMENT LLC | 05/14/2025 | 807.90 K | $298.92 K | 0.00% | 1.54% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 431.04 K | $159.53 K | 17.42% | 0.82% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 05/12/2025 | 274.10 K | $101.42 K | 46.16% | 0.52% |
| RBF CAPITAL, LLC | 05/15/2025 | 250.36 K | $92.63 K | 0.00% | 0.48% |
| CITADEL ADVISORS LLC | 05/15/2025 | 210.88 K | $78.02 K | 358.87% | 0.40% |
| STATE STREET CORP | 05/15/2025 | 168.88 K | $62.49 K | 0.00% | 0.32% |
| LEPERCQ DE NEUFLIZE ASSET MANAGEMENT LLC | 05/13/2025 | 156.30 K | $57.83 K | 27.08% | 0.30% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 138.13 K | $51.50 K | -53.28% | 0.26% |
| SQUAREPOINT OPS LLC | 08/27/2025 | 127.44 K | $47.15 K | 92.45% | 0.24% |
| BBR PARTNERS, LLC | 05/14/2025 | 100.00 K | $37.00 K | 0.00% | 0.19% |
| NIERENBERG INVESTMENT MANAGEMENT COMPANY, INC. | 05/13/2025 | 88.56 K | $32.77 K | 0.00% | 0.17% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 77.20 K | $28.56 K | -56.43% | 0.15% |
| MORGAN STANLEY | 05/15/2025 | 67.34 K | $24.92 K | 0.00% | 0.13% |
| NORTHERN TRUST CORP | 05/13/2025 | 67.20 K | $24.87 K | 0.00% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 60.04 K | $22.22 K | 77.45% | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 05/15/2025 | 50.45 K | $18.00 K | 0.00% | 0.10% |
| UBS GROUP AG | 05/13/2025 | 45.71 K | $16.91 K | 16,343.53% | 0.09% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 44.80 K | $17.00 K | 0.00% | 0.09% |
| KEMPNER CAPITAL MANAGEMENT INC. | 04/21/2025 | 25.48 K | $9.00 K | 0.00% | 0.05% |
| BAADER BANK AKTIENGESELLSCHAFT | 05/08/2025 | 22.68 K | $6.63 K | 100.00% | 0.04% |
| XTX TOPCO LTD | 05/08/2025 | 21.19 K | $7.84 K | 33.22% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 19.75 K | $7.31 K | 100.00% | 0.04% |
| PARADIGM FINANCIAL PARTNERS, LLC | 05/13/2025 | 19.50 K | $7.22 K | 0.00% | 0.04% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 17.02 K | $6.30 K | 0.00% | 0.03% |
| SHULMAN DEMEO ASSET MANAGEMENT LLC | 04/09/2025 | 15.49 K | $5.73 K | 0.00% | 0.03% |
| VIRTU FINANCIAL LLC | 05/12/2025 | 11.92 K | $4.00 K | -75.34% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 10.03 K | $3.11 K | -22.36% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 3.96 K | $1.47 K | 78.87% | 0.01% |
| JPMORGAN CHASE & CO | 05/12/2025 | 1.92 K | $708 | -0.42% | 0.00% |
| FORT VANCOUVER INVESTMENT MANAGEMENT, LLC | 04/25/2025 | 1.60 K | $592 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 793 | $294 | 0.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 05/09/2025 | 700 | $259 | 0.00% | 0.00% |
| FMR LLC | 05/12/2025 | 429 | $159 | -22.70% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 04/17/2025 | 10 | $4 | 0.00% | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/21/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| ENGINEERS GATE MANAGER LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| BFSG, LLC | 04/18/2025 | 0 | $0 | -100.00% | 0.00% |
| TLS ADVISORS LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
Enzo Biochem, Inc. institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Enzo Biochem, Inc.. The most heavily invested institutionals were:
Lepercq Multi-Asset Fund: 123,000
RAYMOND JAMES TRUST N.A.: 17,016
BlackRock Inc.: 955,023
Potomac Capital Management, Inc.: 1.48 M
BDO Wealth Advisors, LLC: 5,000
VIEX Capital Advisors, LLC: 1.33 M
25.65% of Enzo Biochem, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.43 M shares in the last 24 months. This purchase volume represents approximately $2.61 M in transactions.